다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Viridian Therapeutics Inc (VRDN)
Viridian Therapeutics Inc (VRDN) 뉴스

VRDN

Viridian Therapeutics (VRDN)

Viridian Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VRDN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/18	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/09/18	10:00	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/09/13	19:07	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/09/13	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/09/12	12:25	Business Wire	Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/09/11	05:28	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/09/11	05:01	Business Wire	Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/09/10	20:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/09/10	20:00	Business Wire	Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/09/10	05:01	Business Wire	Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/09/06	05:01	Business Wire	Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/08/13	05:06	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/08/08	21:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/08/08	21:15	Business Wire	Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2024 Financial Results	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/08/08	21:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/08/08	05:01	Business Wire	Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/07/25	21:00	Business Wire	Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/07/15	19:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/07/03	21:00	Business Wire	Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/06/11	19:00	Business Wire	Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/06/10	21:05	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/06/07	05:01	Business Wire	Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/05/31	21:00	Business Wire	Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/05/10	21:00	Business Wire	Viridian Therapeutics to Participate in Upcoming May Investor Conferences	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/05/08	20:51	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/05/08	20:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/05/08	20:00	Business Wire	Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/05/03	21:00	Business Wire	Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/04/29	21:00	Business Wire	Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024	NASDAQ:VRDN	Viridian Therapeutics Inc
2024/04/05	05:01	Business Wire	Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VRDN	Viridian Therapeutics Inc

검색 관련기사 보기:NASDAQ:VRDN

1 2 3 4 5 6 7 8 9 10 다음 >>

American Express

Bank of America

BNP Paribas (QX)

US Dollar vs Euro

Health Care Select Sector

US Dollar vs Yen

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관